immunotherapy

You have access
COVID-19 in cancer patients: risk, clinical features, and management
Cuiwei Liu, Yanxia Zhao, Derick Okwan-Duodu, Reva Basho and Xiaojiang Cui

Cancer Biology & Medicine August 2020, 17 (3) 519-527; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0289
You have access
Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
Shaoping Shen, Ling Chen, Jialin Liu, Lin Yang, Mengna Zhang, Lingxiong Wang, Rong Zhang, Yasushi Uemura, Qiyan Wu, Xinguang Yu and Tianyi Liu

Cancer Biology & Medicine August 2020, 17 (3) 555-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0027
You have access
Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors
Min Liu, Qian Sun, Feng Wei and Xiubao Ren

Cancer Biology & Medicine August 2020, 17 (3) 626-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0112
You have access
Triple negative breast cancer: special histological types and emerging therapeutic methods
Lu Cao and Yun Niu

Cancer Biology & Medicine May 2020, 17 (2) 293-306; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0465
You have access
Technical advances in NK cell-based cellular immunotherapy
Fang Fang, Wei Wang, Minhua Chen, Zhigang Tian and Weihua Xiao

Cancer Biology & Medicine November 2019, 16 (4) 647-654; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0187
You have access
The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy
Wenxiao Jia, Qianqian Gao, Anqin Han, Hui Zhu and Jinming Yu

Cancer Biology & Medicine November 2019, 16 (4) 655-670; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0144
You have access
Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities
Guilian Shi, Mingchuan Zhong, Fuli Ye and Xiaoming Zhang

Cancer Biology & Medicine November 2019, 16 (4) 714-728; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0232
You have access
Human natural killer cells for targeting delivery of gold nanostars and bimodal imaging directed photothermal/photodynamic therapy and immunotherapy
Bin Liu, Wen Cao, Jin Cheng, Sisi Fan, Shaojun Pan, Lirui Wang, Jiaqi Niu, Yunxiang Pan, Yanlei Liu, Xiyang Sun, Lijun Ma, Jie Song, Jian Ni and Daxiang Cui

Cancer Biology & Medicine November 2019, 16 (4) 756-770; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0112
You have access
Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients
Yuhan Zhang, Shuaibing Wang, Beibei Yang, Su Lu, Yiyi Du and Hong Liu

Cancer Biology & Medicine May 2019, 16 (2) 350-360; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0378
You have access
The ascent of immune checkpoint inhibitors: is the understudy ready for a leading role?
Amy L. Cummings and Edward B. Garon

Cancer Biology & Medicine November 2017, 14 (4) 341-347; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0090

Main menu

User menu

Search

immunotherapy

Pages

Navigate

More Information

For Authors

Journal Services